Revenue
2023
2024
2025
Medline Inc. (MDLN)
Price—Loading quote
Net income
2023
2024
2025
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 · Dec 31 | 2025 · Dec 16 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $28.43B | — | $25.51B | $23.23B |
| Gross profit | $7.52B | — | $6.98B | $5.88B |
| Research & development | $80.0M | — | $67.0M | $60.0M |
| Operating expenses | $5.31B | — | $4.83B | $4.63B |
| Operating income | $2.21B | — | $2.15B | $1.25B |
| EBITDAderived | $3.22B | — | $3.12B | $2.20B |
| Net income | $1.16B | $1.15B | $1.16B | $234.0M |
| Basic EPSper diluted share | -$0.01 | — | — | — |
| Diluted EPSper diluted share | -$0.01 | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 16, 2026Form 4 · 10b5-1 | Golwas Douglas PChief Commercial Officer | SellClass A Common Stock | 38.0K | $37.05 | $1.41M | 23.9K |
| Jun 16, 2026Form 4 · 10b5-1 | Golwas Douglas PChief Commercial Officer | SellClass A Common Stock | 62.0K | $36.60 | $2.27M | 61.9K |
| Jun 5, 2026Form 4 | CORCORAN JESSI LPrincipal Accounting Officer | BuyClass A Common Stock | 5.0K | $34.15 | $170.8K | 5.0K |
| May 28, 2026Form 4 | Mend Partners II, L.P. +8TenPercentOwner | SellClass A Common Stock · indirect | 1.26M | $36.54 | $46.14M | 6.52M |
| May 28, 2026Form 4 | Mend Partners II, L.P. +8TenPercentOwner | SellClass A Common Stock · indirect | 11.90M | $36.54 | $435.00M | 62.59M |